Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
Braun
F
F
Klinik für Transplantationschirugie, Georg-August-Universität, Göttingen, Germany.
Schütz
E
E
Peters
B
B
Talaulicar
R
R
Grupp
C
C
Undre
N
N
Schäfer
A
A
Armstrong
V W
VW
Oellerich
M
M
Ringe
B
B
D000328:Adult; D000368:Aged; D019540:Area Under Curve; D002102:Cadaver; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019520:Living Donors; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus